$1.1 million grant funds study on why early pregnancy prevents breast cancer

March 06, 2017

EL PASO, Texas - Biomedical scientist Rajkumar Lakshmanaswamy, Ph.D., has received a $1.1 million research grant from the U.S. Department of Defense (DOD) to study how early pregnancy reduces a woman's risk for breast cancer.

"We've known for centuries that women who don't have children run a high risk for breast cancer," says Lakshmanaswamy, a professor of biomedical sciences at Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso). "So what is it about pregnancy, particularly early pregnancy, that reduces a women's lifetime risk of breast cancer?"

Studies have shown that if a woman gives birth to her first child before the age of 20, her risk of developing breast cancer is half that of a woman who has never undergone a full-term pregnancy, or a woman who had her first child after the age of 35. The biological processes that cause this protective effect, however, are not well understood.

With the grant, Lakshmanaswamy hopes to better understand the natural processes behind the phenomenon, which could lead to new prevention and treatment strategies for breast cancer.

The TTUHSC El Paso research team will specifically study growth hormone and prolactin, two hormones known for stimulating breast cancer growth, but that dramatically dip in women after pregnancy. Lakshmanaswamy believes this hormonal reduction in postpartum women affects tissue within the breast, causing it to permanently alter and become resistant to mammary cancer.

"If you think about it, by design, mammals are wired to make babies as soon as they achieve puberty -- except humans, who choose to have babies at later ages," he explains. "So when a woman opts to hold off on children, she may be delaying an important natural process."

The biomedical scientist emphasizes that he does not recommend for women to get pregnant early to avoid breast cancer; he only hopes to gain more knowledge on the protective phenomenon so that it can be translated into a new therapy for breast cancer.

Lakshmanaswamy is the dean of the Graduate School of Biomedical Sciences at TTUHSC El Paso. He earned his doctoral degree from the University of Madras in Chennai, India, and went on to conduct postdoctoral research at the Cancer Research Laboratory at the University of California, Berkeley.
-end-


Texas Tech University Health Sciences Center El Paso

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.